We are live on ! Find out more
AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Est. Return 0.94%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+0.94%
3 Year Est. Return
+28.59%
5 Year Est. Return
+40.78%
10 Year Est. Return
AUM
$253M
AUM Growth
-$17.8M
Cap. Flow
-$26.8M
Cap. Flow %
-10.6%
Top 10 Hldgs %
29.49%
Holding
1,087
New
106
Increased
276
Reduced
238
Closed
96
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
876
Stryker
SYK
$129B
$3K ﹤0.01%
24
TUR icon
877
iShares MSCI Turkey ETF
TUR
$213M
$3K ﹤0.01%
70
VOX icon
878
Vanguard Communication Services ETF
VOX
$5.73B
$3K ﹤0.01%
33
XTN icon
879
State Street SPDR S&P Transportation ETF
XTN
$400M
$3K ﹤0.01%
50
VIVS
880
VivoSim Labs
VIVS
$1.27M
$3K ﹤0.01%
4
LM
881
DELISTED
Legg Mason, Inc.
LM
$3K ﹤0.01%
82
AKS
882
DELISTED
AK Steel Holding Corp
AKS
$3K ﹤0.01%
459
+115
+33% +$985
PNTR
883
DELISTED
Pointer Telocation Ltd.
PNTR
$3K ﹤0.01%
300
SCMP
884
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$3K ﹤0.01%
311
-6,648
-96% -$77.2K
WFM
885
DELISTED
Whole Foods Market Inc
WFM
$3K ﹤0.01%
100
-899
-90% -$27.1K
MEET
886
DELISTED
The Meet Group, Inc. Common Stock
MEET
$3K ﹤0.01%
500
-500
-50% -$2.54K
WNR
887
DELISTED
Western Refining Inc
WNR
$3K ﹤0.01%
86
ABEV icon
888
Ambev
ABEV
$46.8B
$2K ﹤0.01%
300
AFL icon
889
Aflac
AFL
$63.9B
$2K ﹤0.01%
42
-42
-50% -$1.49K
ARGT icon
890
Global X MSCI Argentina ETF
ARGT
$836M
$2K ﹤0.01%
81
CARM
891
DELISTED
Carisma Therapeutics
CARM
$2K ﹤0.01%
50
CLDX icon
892
Celldex Therapeutics
CLDX
$3.22B
$2K ﹤0.01%
33
CNQ icon
893
Canadian Natural Resources
CNQ
$93.3B
$2K ﹤0.01%
123
CSQ icon
894
Calamos Strategic Total Return Fund
CSQ
$3.32B
$2K ﹤0.01%
150
CSTE icon
895
Caesarstone
CSTE
$80.2M
$2K ﹤0.01%
50
-510
-91% -$16.4K
EWY icon
896
iShares MSCI South Korea ETF
EWY
$24.6B
$2K ﹤0.01%
30
FTC icon
897
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
$2K ﹤0.01%
47
GREK
898
Global X MSCI Greece ETF
GREK
$317M
$2K ﹤0.01%
67
IHI icon
899
iShares US Medical Devices ETF
IHI
$3.34B
$2K ﹤0.01%
+66
New +$1.6K
IYC icon
900
iShares US Consumer Discretionary ETF
IYC
$1.22B
$2K ﹤0.01%
48
-72,824
-100% -$2.87M

Similar funds

Advantage Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Advantage Investment Management held 1,087 positions worth $253M, down 6.6% from $270M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Advantage Investment Management withdrew a net $26.8M in Q1 2017, closing 96 positions and reducing 238 holdings. Its most notable exit was Invesco Emerging Markets Sovereign Debt ETF, an estimated $3.73M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.2% of assets, up from 7.1% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Advantage Investment Management opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $4.09M.

  • Advantage Investment Management's largest Q1 2017 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 44,699 shares worth $4.09M.
  • Advantage Investment Management added most to iShares MSCI USA Quality Factor ETF in Q1 2017, an estimated $7.33M increase.
  • Advantage Investment Management's biggest Q1 2017 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $9.86M.
  • Advantage Investment Management fully exited Invesco Emerging Markets Sovereign Debt ETF in Q1 2017, selling an estimated $3.73M.
  • Advantage Investment Management's ten largest holdings make up 29% of its $253M portfolio in Q1 2017.
  • Advantage Investment Management opened 106 new positions and closed 96 in Q1 2017.
  • Advantage Investment Management's portfolio value fell 6.6% quarter-over-quarter to $253M.

Based on Advantage Investment Management's 13F filing for Q1 2017, filed 8 May 2017.